RE
NMTR

RBC Europe’s 9 Meters Biopharma NMTR Stock Holding History

RBC Europe’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,250
Closed -$32.5K – 1224
2021
Q3 		$32.5K Hold
1,250
– – ﹤0.01% 671
2021
Q2 		$27.5K Hold
1,250
– – ﹤0.01% 736
2021
Q1 		$29.3K Hold
1,250
– – ﹤0.01% 671
2020
Q4 		$21.5K Hold
1,250
– – ﹤0.01% 698
2020
Q3 		$20.4K Hold
1,250
– – ﹤0.01% 644
2020
Q2 		$14.3K Hold
1,250
– – ﹤0.01% 689
2020
Q1 		$12.6K Hold
1,250
– – ﹤0.01% 648
2019
Q4 		$13.9K Hold
1,250
– – ﹤0.01% 726
2019
Q3 		$26.8K Hold
1,250
– – ﹤0.01% 574
2019
Q2 		$29K Buy
+1,250
New +$37.5K ﹤0.01% 575

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

RBC Europe's NMTR Position: Q4 2021 in Review

RBC Europe sold out of 9 Meters Biopharma (NMTR) in Q4 2021, closing a stake of 1,250 shares — an estimated $32.5K sold.

RBC Europe first reported a position in NMTR in Q2 2019 and held it in 10 quarters. The position peaked at $32.5K in Q3 2021. 104 funds tracked by Wall St. Rank hold NMTR as of Q4 2021.

  • RBC Europe reported no remaining 9 Meters Biopharma position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 1,250 9 Meters Biopharma shares in Q4 2021, an estimated $32.5K.
  • RBC Europe first reported a position in 9 Meters Biopharma in Q2 2019 and held it in 10 quarters.
  • RBC Europe's 9 Meters Biopharma position peaked at $32.5K in Q3 2021.
  • 104 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.